ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物醫藥B類股
483.155
-13.603
-2.74%
手動刷新
漲家數:
7
跌家數:
23
平家數:
3
市盈率:
- -
高:
496.758
開:
496.758
低:
480.328
收:
496.758
成交量:
1.15億
成交額:
26.12億
市值:
3,069.30億
流通市值:
2,732.98億
資料載入中...
總覽
新聞
執行董事王玉曉減持榮昌生物(09995)1.35萬股 每股作價約81.54港元
智通财经
·
09/02
深入挖掘創新項目 深圳市市場監督管理局組織開展2026年醫療器械重點創新項目路演遴選活動
深圳新闻网
·
09/02
東方證券股份有限公司(DFZQ)減持康諾亞-B(02162.HK)4.8萬股 每股作價78.401港元
智通财经
·
09/02
榮昌生物(09995.HK)購買3億元理財產品
智通财经
·
09/02
勁方醫藥-B(02595)9月2日斥資107.63萬港元回購3.9萬股
智通财经
·
09/02
港股收盤(09.02) | 恒指收跌0.07% 部分醫藥股逆市走高 汽車、有色金屬等承壓
智通财经
·
09/02
迪哲醫藥二度遞表港交所:上半年虧損超2億,「小眾靶點」天花板與現金流雙重壓力並存
蓝鲸财经
·
09/02
新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證
智通财经
·
09/02
前8月全球醫藥投融資按年增72%,行情回暖可期?
新浪基金
·
09/02
國金證券:雙輪驅動醫療器械內外復甦 聚焦創新與出海主線
智通财经
·
09/02
基石藥業-B(02616)股價上升8.326%,現價港幣$6.18
阿斯达克财经
·
09/02
港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍 戰略重心轉向高附加值醫療器械賽道
智通财经
·
09/02
港股異動 | 啓明醫療-B(02500)午後升逾13% 參投企業Pi-Cardia獲美敦力8000萬美金戰略投資
智通财经
·
09/02
李氏大藥廠(00950)股價下跌5.344%,現價港幣$1.24
阿斯达克财经
·
09/02
單日暴漲177%的莫德納,對全球醫藥產業意味着什麼?
蓝鲸财经
·
09/02
禮邦醫藥-B(09637)股價下跌8.404%,現價港幣$27.9
阿斯达克财经
·
09/02
港股異動 | 基石藥業-B(02616)早盤升逾4% 普拉替尼納入醫保後銷售放量 上半年收入激增超3倍
智通财经
·
09/02
大行評級丨小摩:康方生物上半年收入遠遜預期,目標價降至125港元
格隆汇
·
09/02
再鼎醫藥早盤漲逾6% DLL3 ADC啓動一線SCLC全球三期臨床
新浪港股
·
09/02
歌禮制藥-B早盤升逾8% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥
新浪港股
·
09/02
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK1574/news?page=13"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":483.15506,"timestamp":1789114133774,"preClose":496.75812,"halted":0,"volume":115323363,"delay":0,"changeRate":-0.027384,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-13.603058,"latestTime":"09-11 16:00:00","open":496.75812,"high":496.75812,"low":480.32812,"amount":2611810568,"amplitude":0.033074,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":3.606253,"peRate":160.422718,"turnoverRate":0.004215,"increases":6,"decrements":25,"flats":1,"marketCap":306930068880,"floatMarketCap":273297591592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":496.75812,"amplitude":0.033074,"preClose":496.75812,"low":480.32812,"pbRate":"3.606253","latestPrice":483.15506,"volume":115323363,"delay":0,"open":496.75812,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":532.025,"twentyDayClose":518.327,"sixtyDayClose":434.471,"secType":"PLATE","market":"HK","turnoverRate":0.004215,"peRate":160.422718,"marketCap":306930068880,"floatMarketCap":273297591592,"timestamp":1789114133774,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":23,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:13,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664819359","title":"執行董事王玉曉減持榮昌生物(09995)1.35萬股 每股作價約81.54港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819359","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819359?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:38","pubTimestamp":1788349091,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,8月27日,执行董事王玉晓减持荣昌生物(09995)1.35万股,每股作价81.5352港元,总金额约为110.07万港元。减持后最新持股数目为2227.86万股,最新持股比例为10.68%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","09995","BK1574","BK1583","EWH","LU1969619763.USD","LU1064130708.USD","LU2328871848.SGD","LU2488822045.USD","BK0239","BK1161","LU2148510915.USD","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811819","title":"深入挖掘創新項目 深圳市市場監督管理局組織開展2026年醫療器械重點創新項目路演遴選活動","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811819","media":"深圳新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811819?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:25","pubTimestamp":1788348300,"startTime":"0","endTime":"0","summary":"深圳市市场监督管理局已连续两年开展医疗器械重点创新项目路演遴选活动。2026年深圳市市场监督管理局将延续去年经验做法,为遴选出的项目提供快速链接服务,助力项目加快注册审批、实现成果转化。下一步,深圳市市场监督管理局将根据本次路演遴选结果,向国家药监局、省药监局及产业部门精准推荐重点服务项目。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-02/doc-iniqmwqu2753585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDEV","HART","AGNG","BK1583","BK1100","PTH","09996","BK1574","159883","IEIH","LGHT","RSPH","LNGR","MEDX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664546816","title":"東方證券股份有限公司(DFZQ)減持康諾亞-B(02162.HK)4.8萬股 每股作價78.401港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664546816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664546816?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:19","pubTimestamp":1788347999,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1574","02162","BK1564","BK1147","BK1161","BK1587","03958"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781507","title":"榮昌生物(09995.HK)購買3億元理財產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664781507?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:11","pubTimestamp":1788347501,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2328871848.SGD","LU1969619763.USD","BK1583","BK1161","BK1574","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815269","title":"勁方醫藥-B(02595)9月2日斥資107.63萬港元回購3.9萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815269","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:06","pubTimestamp":1788347190,"startTime":"0","endTime":"0","summary":"智通财经APP讯,劲方医药-B(02595)发布公告,于2026年9月2日,该公司斥资107.63万港元回购3.9万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","159938","BK1515","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892707","title":"港股收盤(09.02) | 恒指收跌0.07% 部分醫藥股逆市走高 汽車、有色金屬等承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892707","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664892707?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 16:26","pubTimestamp":1788337611,"startTime":"0","endTime":"0","summary":"截至收盘,恒生指数跌0.07%或18.52点,报25311.21点,全日成交额2166.91亿港元;恒生国企指数跌0.15%,报8450.1点;恒生科技指数跌0.74%,报4517.16点。汽车股普遍承压。有色金属走势低迷。部分医药股表现亮眼。新意网集团发布截至2026年6月30日止的全年业绩,该集团取得收入31.17亿港元,同比增加6.09%;公司股东应占溢利11.46亿港元,同比增加16.96%;每股基本盈利28.07港仙。建滔积层板上月底宣布2026年以来第七次宣布涨价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07200","RJZ","513600","BK1190","01417","BK1583","82800","01208","00568","BK1588","159871","BK1542","VXUS","BK1594","BK1574","83115","BK4588","IDRV","BK1515","03115","000819.SH","HSImain","159938","MHImain","BK1539","BK1161","HSI","09115","LU1794554557.SGD","BK1592","03419","165316","07300","02015","07500","02800","BK1587","BK1158","03037","BK4585","09939","KCAI","01686","MCHmain","BK1202","02833","BK1575","02096","HHImain","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894762","title":"迪哲醫藥二度遞表港交所:上半年虧損超2億,「小眾靶點」天花板與現金流雙重壓力並存","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894762","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894762?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:46","pubTimestamp":1788335190,"startTime":"0","endTime":"0","summary":"目前,迪哲医药两款核心产品舒沃哲和高瑞哲均已进入国家医保目录。截至2026年中,迪哲医药无控股股东和实际控制人。就在9月1日,迪哲医药发布公告称,公司与阿斯利康签署《许可协议》,授予阿斯利康在全球范围内独家开发、商业化舒沃哲的权利。不过,市场依然对两款产品的天花板存在争议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788335043232116627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1574","BK4585","159938","BK1161","BK1515","09939","159399","IPOS","SPHQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489420","title":"新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489420","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489420?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335097,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新华医疗 发布公告,公司近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》、子公司新华手术器械有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》。该产品取得注册证后,不仅丰富了公司在微创腔镜领域的产品矩阵,也提升了在胸腔镜手术领域的综合竞争力,有助于扩大市场覆盖范围并增强品牌影响力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IEIH","BK1100","159883","BK1574","RSPH","09996","BK0028","PTH","BK0188","LGHT","BK1583","MDEV","AGNG","BK0251","HART","GDOC","LNGR","600587","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894186","title":"前8月全球醫藥投融資按年增72%,行情回暖可期?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894186","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894186?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:39","pubTimestamp":1788334740,"startTime":"0","endTime":"0","summary":"据机构最新数据显示,2026年前8个月全球医药投融资明显回暖,全球药品一、二级融资金额合计538亿美元、同比增长72%,约为2025年全年的92%。截至8月30日,5500余家A股上市公司披露上半年研发投入情况,合计研发投入超过8100亿元,同比增长超过7%,生物医药成为上半年A股公司投入研发资金的“高地”之一。其中,以H股42家和A股58家创新药企业为样本,2026年上半年收入、归母净利润增速分别达21.3%、88.8%,显著优于医药板块整体水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-09-02/doc-iniqmmyy2904992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1161","BK1574","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894673","title":"國金證券:雙輪驅動醫療器械內外復甦 聚焦創新與出海主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894673?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:25","pubTimestamp":1788333958,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,国金证券发布研报称,医疗器械板块当前投资应紧扣“出海拓增量、创新守利润”的双轮驱动逻辑,同时把握国内需求复苏节奏。出海能有效分散集采风险,打开成长天花板,而持续的高强度研发投入则是维持高毛利率、抵御价格战的关键护城河。国金证券主要观点如下:医疗设备收入端同比稳定增长,毛利率略有承压。医疗耗材收入增速快速恢复,毛利率显著提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","159883","RSPH","AGNG","BK0276","BK1583","IEIH","600109","BK0028","09996","MDEV","HART","LGHT","LNGR","BK0183","BK0012","BK1574","BK1100","PTH","BK0188","BK0201","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891796","title":"基石藥業-B(02616)股價上升8.326%,現價港幣$6.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891796","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891796?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:05","pubTimestamp":1788332700,"startTime":"0","endTime":"0","summary":"[上升股]基石药业-B(02616) 股价在下午03:04比前收市价上升8.326%,现股价为港币$6.18。至目前为止,今日最高价为$6.18,而最低价为$5.735。总成交量为647.25万股,总成交金额为港币$3.882千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609022233/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609022233/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899822","title":"港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍 戰略重心轉向高附加值醫療器械賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899822","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899822?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 14:04","pubTimestamp":1788329049,"startTime":"0","endTime":"0","summary":"消息面上,近期,今海医疗科技披露2026年中期业绩。2026年上半年,集团实现收益3402.1万新加坡元,同比大幅增长134.16%,展现出强劲的销售增长动能。业务端,2026年上半年,公司收入结构显著优化,战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。继2025年医疗器械销售收益实现良好增长后,2026年上半年该业务收益同比激增301.5%,达到2542.7万新加坡元,可持续增长动力充足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","HART","LGHT","159883","LNGR","BK4588","VXUS","BK4585","MDEV","RSPH","GDOC","IEIH","BK1574","BK1583","MEDX","KCAI","09996","BK1150","BK1100","PTH","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664839899","title":"港股異動 | 啓明醫療-B(02500)午後升逾13% 參投企業Pi-Cardia獲美敦力8000萬美金戰略投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2664839899","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664839899?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 13:59","pubTimestamp":1788328771,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,启明医疗-B午后涨超13%。截至发稿,涨13.24%,报1.155港元,成交额243.90万港元。消息面上,启明医疗参与投资千万美金的以色列创新医疗器械公司Pi-Cardia宣布获得美敦力8,000万美金的战略投资,在达成里程碑后,美敦力有权以不超过2.1亿美元的对价收购Pi-Cardia。此次合作标志着Shortcut产品进入全球商业化加速阶段,也将进一步巩固Pi-Cardia在结构性心脏病领域的创新领导者地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02500","BK1583","KCAI","BK1100","VXUS","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899366","title":"李氏大藥廠(00950)股價下跌5.344%,現價港幣$1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899366","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899366?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 13:55","pubTimestamp":1788328500,"startTime":"0","endTime":"0","summary":"[下跌股]李氏大药厂(00950) 股价在下午01:54比前收市价下跌5.344%,现股价为港币$1.24。至目前为止,今日最高价为$1.31,而最低价为$1.24。总成交量为162.4万股,总成交金额为港币$205.398万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609024050/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609024050/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","BK1191","06622","00950","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589566","title":"單日暴漲177%的莫德納,對全球醫藥產業意味着什麼?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589566","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589566?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 12:10","pubTimestamp":1788322216,"startTime":"0","endTime":"0","summary":"引发一切的,是当天莫德纳与默沙东联合公布的一份三期临床试验顶线结果。177%不是一天涨出来的要更进一步理解此次大涨,需要先理解市场之前对莫德纳的评判逻辑。默沙东为此等了十年,2016年签下合作协议并支付2亿美元首付款,2018年追加1.25亿美元战略投资,2022年正式行使共同开发选择权。8月20日下跌23.55%之后,莫德纳并没有跌回去。这里值得单独一提的是8月20日涨幅最大的云顶新耀,这","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788143888266092586","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IYH","BK4535","MRK","LU2361044865.SGD","LU0130102774.USD","IE00BN8TJ469.HKD","LU2125909593.SGD","01952","IE00BLSP4452.SGD","LU1941712348.USD","JDOC","LU1037948897.HKD","LU0058720904.USD","LU1066053197.SGD","LU0098860793.USD","IE000M9KFDE8.USD","MRNY","LU2125154935.USD","LU1989772923.USD","LU2089984988.USD","LU0861579265.USD","PPH","LU0106261372.USD","LU1066051811.HKD","LU2112291526.USD","BK4533","LU0124676726.USD","BK4588","LU1093756168.USD","BNTX","LU0689626769.HKD","LU1037948541.HKD","LU0238689110.USD","LU0320765646.SGD","IE0002141913.USD","LU1974910355.USD","LU1934455863.HKD","BK4516","LU0006306889.USD","IE00B4R5TH58.HKD","LU1201861249.SGD","LU0823416689.USD","SG9999002232.USD","LU2023250843.SGD","SG9999014575.USD","IE00B2B36J28.USD","LU1023059063.AUD","MRNX","LU0965509283.SGD","SG9999001440.SGD","LU0211331839.USD","LGHT","LU0234572021.USD","IE00BSNM7G36.USD","SG9999014559.SGD","FHLC","LU1116320737.USD","LU1066051498.USD","LU1057294990.SGD","BK4585","LU0203345920.USD","FTXH","LU0965509101.SGD","LU1430594728.SGD","LU0942090050.USD","BK1583","BK4548","BK1574","HRTS","LU0265550946.USD","LU1093756325.SGD","LU2461242641.AUD","SG9999014567.USD","LU2491050071.SGD","BMED","LU1032466523.USD","BK1161","LU1934455194.USD","LU2125154778.USD","LU0985320562.USD","IDNA","LU0859254822.USD","LU2468319806.SGD","LU0070302665.USD","IE00BBT3K403.USD","LU0265550359.USD","LU1061106388.HKD","MRNA","BK4007","IHE","LU1035773651.USD","LU0208291251.USD","LU2361044949.HKD","LU2361045086.USD","LU1699723380.USD","LU2324357040.USD","WDNA","LU2360032135.SGD","SG9999001176.SGD","PAWZ","LU1571399168.USD","VHT","LU1066051225.USD","LU1917777945.USD","LU0965508806.USD","LU1923622614.USD","LU1989771016.USD","SG9999001176.USD","BK4559","BK4550","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4139","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2491050154.USD","IXJ","LU0122379950.USD","SG9999014542.SGD","IE0009355771.USD","TRUH","LU0203347892.USD","LU0477156953.USD","XLV","RXL","GDOC","LU0266013472.USD","LU1116320901.HKD","LU1989772840.SGD","LU1585245621.USD","LU2433249047.HKD","SGXZ57979304.SGD","GNOM","LU1929549753.HKD","LU1934455277.USD","SG9999015358.SGD","BK4551","LU0130517989.USD","LU1941712264.USD","BK4568","LU0432979614.USD","BK4501","SG9999015341.SGD","LU0648001328.SGD","LU2125909247.SGD","SG9999002224.SGD","BK4534","LU2491049909.HKD","SG9999013999.USD","LU0320765489.SGD","BK4532","LU0965509010.AUD","LU1983299246.USD","LU2023250504.SGD","LU2106854487.HKD","LU1069347547.HKD","LU2357627491.SGD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1162221912.USD","LU0980610538.SGD","LU1291159041.SGD","LU0868494708.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664895554","title":"禮邦醫藥-B(09637)股價下跌8.404%,現價港幣$27.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2664895554","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664895554?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 11:55","pubTimestamp":1788321300,"startTime":"0","endTime":"0","summary":"[下跌股]礼邦医药-B(09637) 股价在上午11:55比前收市价下跌8.404%,现股价为港币$27.9。至目前为止,今日最高价为$30.5,而最低价为$27.9。总成交量为43.97万股,总成交金额为港币$1.28千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609023368/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609023368/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1515","09637","BK1574","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664893277","title":"港股異動 | 基石藥業-B(02616)早盤升逾4% 普拉替尼納入醫保後銷售放量 上半年收入激增超3倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893277","media":"智通财经","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893277?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 11:42","pubTimestamp":1788320549,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,基石药业-B早盘涨超4%。消息面上,基石药业发布中期业绩,上半年收入2.05亿元人民币,同比增加314.75%。其中药品销售收入1.83亿元,主要来自普拉替尼、阿伐替尼和舒格利单抗。普拉替尼自2026年1月纳入国家医保目录后,截至2026年7月院内销售额同比增长近500%,成为收入增长的主要驱动力。恒生综合指数变动将于9月4日收市后实施并于9月7日起生效,届时沪深交易所会相应调整港股通可投资标的范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","02616","BK1161","BK1574","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664689817","title":"大行評級丨小摩:康方生物上半年收入遠遜預期,目標價降至125港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664689817","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664689817?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 10:39","pubTimestamp":1788316776,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2399975544.HKD","LU0348783233.USD","IE00BPRC5H50.USD","LU0348825331.USD","LU1961090484.USD","LU2476274720.SGD","BK1574","IE00B543WZ88.USD","LU1794554557.SGD","LU0348784397.USD","LU0348767384.USD","LU2476274308.USD","LU0634319403.HKD","LU0417516902.SGD","LU2778985437.USD","BK1161","LU0417516571.SGD","LU1720050803.USD","LU0348827113.USD","09926","LU0561508036.HKD","LU2488822045.USD","LU0417516738.SGD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348735423.USD","KURE","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898546","title":"再鼎醫藥早盤漲逾6% DLL3 ADC啓動一線SCLC全球三期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898546","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664898546?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 10:16","pubTimestamp":1788315360,"startTime":"0","endTime":"0","summary":"模拟交易客户端再鼎医药早盘涨逾6%。截至发稿,股价上涨5.97%,现报20.60港元,成交额5967.91万港元。8月31日,再鼎医药在Clinicaltrials.gov网站上注册了ZL-1310+PD-L1抗体一线治疗ES-SCLC的全球三期临床试验。该全球三期临床拟入组530例一线ES-SCLC患者,预计2030年6月初步完成。2026 年下半年重要催化剂包括:Zoci一线小细胞肺癌联合治疗数据公布、1L SCLC 及肺外神经内分泌癌注册性开发推进;ZL-1503首次人体数据公布等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-02/doc-iniqkzme7832199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK1588","BK1574","BK4588","LU2488822045.USD","BK1161","BK4548","09688","BK4526","ZLAB","BK4531","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898526","title":"歌禮制藥-B早盤升逾8% ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898526","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664898526?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 10:13","pubTimestamp":1788315180,"startTime":"0","endTime":"0","summary":"模拟交易客户端歌礼制药-B早盘涨超8%,截至发稿,股价上涨8.07%,现报10.31港元,成交额926.46万港元。近日,歌礼制药-B发布公告,ASC30用于长期体重管理的全球III期临床项目已完成首例受试者给药。ASC30是一款歌礼专有的、正在临床研究中的每日一次口服小分子胰高血糖素样肽-1受体激动剂,开发用于长期体重管理和糖尿病治疗。公告称,歌礼制药-B预计将于2028年第三季度公布AURORA III期临床项目的顶线数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-02/doc-iniqkzma1311603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01672","BK1191","01477","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":13,"totalSize":344,"code":"91000000","status":"200"}]}}